BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 237499)

  • 1. Plasma albumin concentration and diphenylhydantoin binding in man.
    Porter RJ; Layzer RB
    Arch Neurol; 1975 May; 32(5):298-303. PubMed ID: 237499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma albumin concentration and binding of diphenylhydantoin in man.
    Porter RJ; Layzer RB
    Trans Am Neurol Assoc; 1974; 99():45-9. PubMed ID: 4463562
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma protein binding, plasma concentrations, and effects of diphenylhydantoin in man.
    Lund L; Lunde PK; Rane A; Borga O; Sjöqvist F
    Ann N Y Acad Sci; 1971 Jul; 179():723-8. PubMed ID: 4998913
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma protein binding of diphenylhydantoin in man.
    Lunde KM
    Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():152-5. PubMed ID: 5316396
    [No Abstract]   [Full Text] [Related]  

  • 5. Human brain, cerebrospinal fluid, and plasma concentrations of diphenylhydantoin and phenobarbital.
    Vajda F; Williams FM; Davidson S; Falconer MA; Breckenridge A
    Clin Pharmacol Ther; 1974 Jun; 15(6):597-603. PubMed ID: 4841972
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma concentrations of unbound phenytoin in the management of epilepsy.
    Kilpatrick CJ; Wanwimolruk S; Wing LM
    Br J Clin Pharmacol; 1984 May; 17(5):539-46. PubMed ID: 6733002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma protein binding of diphenylhydantoin in patients with epilepsy. Agreement between the unbound fraction in plasma and the concentration in the cerebrospinal fluid.
    Lund L; Berlin A; Lunde KM
    Clin Pharmacol Ther; 1972; 13(2):196-200. PubMed ID: 5017373
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma protein binding of drugs as a function of age in adult human subjects.
    Bender AD; Post A; Meier JP; Higson JE; Reichard G
    J Pharm Sci; 1975 Oct; 64(10):1711-3. PubMed ID: 1185544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between phenobarbital and diphenylhydantoin in animals and in epileptic patients.
    Morselli PL; Rizzo M; Garattini S
    Ann N Y Acad Sci; 1971 Jul; 179():88-107. PubMed ID: 5285399
    [No Abstract]   [Full Text] [Related]  

  • 10. Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding.
    Odar-Cederlöf I; Borgå O
    Eur J Clin Pharmacol; 1974; 7(1):31-7. PubMed ID: 4852619
    [No Abstract]   [Full Text] [Related]  

  • 11. Diphenylhydantoin: correlation between protein binding and albumin concentration.
    Gugler R; Azarnoff DL; Shoeman DW
    Klin Wochenschr; 1975 May; 53(9):445-6. PubMed ID: 1152355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interaction: diazoxide and diphenylhydantoin.
    Roe TF; Podosin RL; Blaskovics ME
    J Pediatr; 1975 Sep; 87(3):480-4. PubMed ID: 1165531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic response relationship to phenobarbital and diphenylhydantoin serum and cerebrospinal fluid levels in epileptics.
    Volanschi D; Pintilie C; Florescu D; Tudor S
    Neurol Psychiatr (Bucur); 1975; 13(3):217-23. PubMed ID: 1188280
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plasma concentration of phenytoin in epileptics--importance for the clinician].
    Deonna T; de Crousaz G; Magrini G; Bechtel P; Schelling JL
    Schweiz Med Wochenschr; 1975 Jul; 105(30):936-41. PubMed ID: 1153992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gas chromatographic assay of underivatized 5,5-diphenylhydantoin (dilantin) in plasma extracts.
    Sampson D; Harasymiv I; Hensley WJ
    Clin Chem; 1971 May; 17(5):382-5. PubMed ID: 5573401
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of equilibrium dialysis, ultrafiltration, and gel permeation chromatography for the determination of free fractions of phenobarbital and phenytoin.
    Melten JW; Wittebrood AJ; Willems HJ; Faber GH; Wemer J; Faber DB
    J Pharm Sci; 1985 Jun; 74(6):692-4. PubMed ID: 4020659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of phenobarbital on the half-life of diphenylhydantoin in man.
    Kristensen M; Hansen JM; Skovsted L
    Acta Med Scand; 1969 Apr; 185(4):347-50. PubMed ID: 5806342
    [No Abstract]   [Full Text] [Related]  

  • 18. Unbound phenytoin plasma concentrations in patients comedicated with sodium valproate--the predictive value of plasma albumin concentration.
    Johnson GJ; Kilpatrick CJ; Bury RW; Fullinfaw RO; Moulds RF
    Br J Clin Pharmacol; 1989 Jun; 27(6):843-9. PubMed ID: 2503019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of age, sex, obesity, and pregnancy on plasma diphenylhydantoin levels.
    Sherwin AL; Loynd JS; Bock GW; Sokolowski CD
    Epilepsia; 1974 Dec; 15(4):507-21. PubMed ID: 4473337
    [No Abstract]   [Full Text] [Related]  

  • 20. The alteration of plasma proteins in uremia as reflected in the ability to bind diphenylhydantoin.
    Shoeman DW; Benjamin DM; Azarnoff DL
    Ann N Y Acad Sci; 1973 Nov; 226():127-30. PubMed ID: 4520391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.